DOXEPIN HYDROCHLORIDE
- Product NDC
- 62332-639
- 11-digit product format
- 623320639
- Labeler code
- 62332
- Product ID
- 62332-639_c3977b05-a9fc-4cc4-adfc-731abe6613dd
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- DOXEPIN HYDROCHLORIDE
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Alembic Pharmaceuticals Inc.
- Application
- ANDA215076
- Marketing category
- ANDA
- Marketing start
- 2021-04-23
- Substance
- DOXEPIN HYDROCHLORIDE
- Active strength
- 75 mg/1
- Pharmacologic classes
- Tricyclic Antidepressant [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A215076-001 | DOXEPIN HYDROCHLORIDE | DOXEPIN HYDROCHLORIDE | EQ 10MG BASE | CAPSULE / ORAL | AB | 2021-04-21 | |
| A215076-002 | DOXEPIN HYDROCHLORIDE | DOXEPIN HYDROCHLORIDE | EQ 25MG BASE | CAPSULE / ORAL | AB | 2021-04-21 | |
| A215076-003 | DOXEPIN HYDROCHLORIDE | DOXEPIN HYDROCHLORIDE | EQ 50MG BASE | CAPSULE / ORAL | AB | 2021-04-21 | |
| A215076-004 | DOXEPIN HYDROCHLORIDE | DOXEPIN HYDROCHLORIDE | EQ 75MG BASE | CAPSULE / ORAL | AB | 2021-04-21 | |
| A215076-005 | DOXEPIN HYDROCHLORIDE | DOXEPIN HYDROCHLORIDE | EQ 100MG BASE | CAPSULE / ORAL | AB | 2021-04-21 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A215076-001 | AB |
| A215076-002 | AB |
| A215076-003 | AB |
| A215076-004 | AB |
| A215076-005 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A215076-001 | DOXEPIN HYDROCHLORIDE | EQ 10MG BASE | CAPSULE / ORAL | AB | 2021-04-21 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A215076-002 | DOXEPIN HYDROCHLORIDE | EQ 25MG BASE | CAPSULE / ORAL | AB | 2021-04-21 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A215076-003 | DOXEPIN HYDROCHLORIDE | EQ 50MG BASE | CAPSULE / ORAL | AB | 2021-04-21 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A215076-004 | DOXEPIN HYDROCHLORIDE | EQ 75MG BASE | CAPSULE / ORAL | AB | 2021-04-21 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A215076-005 | DOXEPIN HYDROCHLORIDE | EQ 100MG BASE | CAPSULE / ORAL | AB | 2021-04-21 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A215076-001 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A215076-002 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A215076-003 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A215076-004 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A215076-005 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| DOXEPIN HYDROCHLORIDE | DOXEPIN HYDROCHLORIDE | Bryant Ranch Prepack | 09a70f17-f934-4b4b-9277-6351d906ab47 | 2025-10-24 | Boxed warning, Warnings, Adverse reactions | 215076 ANDA215076 |
| DOXEPIN HYDROCHLORIDE | DOXEPIN HYDROCHLORIDE | REMEDYREPACK INC. | 21dc77be-23af-4a1f-b189-dfee8ae2f894 | 2025-10-01 | Boxed warning, Warnings, Adverse reactions | 215076 ANDA215076 |
| DOXEPIN HYDROCHLORIDE | DOXEPIN HYDROCHLORIDE | Alembic Pharmaceuticals Inc. | 4920401a-cde5-404b-82aa-c3c0e8911065 | 2025-07-17 | Boxed warning, Warnings, Adverse reactions | 215076 ANDA215076 62332-639 |
| DOXEPIN HYDROCHLORIDE | DOXEPIN HYDROCHLORIDE | Bryant Ranch Prepack | 06e027bb-516d-4a1d-b5a0-a66c051eb367 | 2025-01-23 | Boxed warning, Warnings, Adverse reactions | 215076 ANDA215076 |
| DOXEPIN HYDROCHLORIDE | DOXEPIN HYDROCHLORIDE | Bryant Ranch Prepack | 19c8ad61-4e4f-4c59-b196-34a4e470459f | 2024-11-13 | Boxed warning, Warnings, Adverse reactions | 215076 ANDA215076 |
| Doxepin HCL | DOXEPIN HCL | Direct_rx | 21c64f9f-cee2-60b0-e063-6294a90ae97e | 2024-09-10 | Boxed warning, Warnings, Adverse reactions | 215076 ANDA215076 |
| DOXEPIN HYDROCHLORIDE | DOXEPIN HYDROCHLORIDE | Boswell Pharmacy Services LLC d/b/a BPS Wholesale | 214bae5d-36e2-47ae-e063-6294a90a7ddd | 2024-09-04 | Boxed warning, Warnings, Adverse reactions | 215076 ANDA215076 |
| DOXEPIN HYDROCHLORIDE | DOXEPIN HYDROCHLORIDE | Advanced Rx of Tennessee, LLC | 1cec730e-3218-ddf6-e063-6294a90a916e | 2024-07-10 | Boxed warning, Warnings, Adverse reactions | 215076 ANDA215076 |
| DOXEPIN HYDROCHLORIDE | DOXEPIN HYDROCHLORIDE | A-S Medication Solutions | 890248d7-73b1-4ed3-b252-85775defdf34 | 2024-06-25 | Boxed warning, Warnings, Adverse reactions | 215076 ANDA215076 |
| DOXEPIN HYDROCHLORIDE | DOXEPIN HYDROCHLORIDE | Alembic Pharmaceuticals Limited | 842b595b-dc54-4898-a178-1d2241cc065f | 2023-01-27 | Boxed warning, Warnings, Adverse reactions | 215076 ANDA215076 |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- DOXEPIN HYDROCHLORIDE
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| DOXEPIN HYDROCHLORIDE | 75 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 3U9A0FE9N5 | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 4920401a-cde5-404b-82aa-c3c0e8911065 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| f6fcd62d-384f-5faa-05d7-c5d5903c6c43 | Product name | 4 | 20250515 |
| 3d5463a5-d368-9c2b-b40c-0f2b688e406e | Product name | 9 | 20240805 |
| 750bc85a-c69c-4145-a865-3f1124677d16 | Product name | 3 | 20240321 |
| eda77195-5c17-5c7f-a6a7-8c80d2f8ae5f | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 62332-639-31 | DOXEPIN HYDROCHLORIDE | 100 in 1 BOTTLE | CAPSULE | 100 | 7 | |
| 62332-639-91 | DOXEPIN HYDROCHLORIDE | 1000 in 1 BOTTLE | CAPSULE | 1000 | 7 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 62332-639-31 | EA - Each | 62332-639 | fb842a4f-3ea3-4ea1-9d2d-95cecd37496d | 1 | 2021-09-07 |
DailyMed Dashboard NDC Coverage#
DailyMed RxNorm Mappings#
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 62332-639-31 | 62332063931 | 100 CAPSULE in 1 BOTTLE (62332-639-31) | 100 capsule | 2021-04-23 | 0000-00-00 | No | No | Current |
| 62332-639-91 | 62332063991 | 1000 CAPSULE in 1 BOTTLE (62332-639-91) | 1000 capsule | 2021-04-23 | 0000-00-00 | No | No | Current |